← Leaderboards
Jennifer Lin Holter Chakrabarty
University Of Oklahoma Hlth Sciences Ctr
$1,638,189
Attributed
$3,276,377
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $750.6K · FY2019–24$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,276,377 · 2
By mechanism
R01$2,913,713 · 1
R21$362,664 · 1
Top collaborators
- Kirsten Williams5 shared
- Lacey R Mcnally2 shared
Most similar at University Of Oklahoma Hlth Sciences Ctr
Same institution · by research overlap
- Lacey R McNally$8,482,397
- Ajay Jain$1,449,469
- Robert S Mannel$9,366,958
Others in their field
Other Emerging Leaders on “Chemotherapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Olwen Hahn · Brigham And Women'S Hospital$13,557,463
- James Dale Berry · Brigham And Women'S Hospital$11,004,714
- Jessica Scott · Sloan-Kettering Inst Can Research$7,160,357
- Vera Hoffman · Reveal Pharma$6,103,452
Research focus
ChemotherapyBiological MarkersImmune SystemLiverComplicationDiagnosisHematopoietic Stem Cell TransplantationImageTransplant RecipientsAllogenicHigh RiskBone MarrowAdultBone Marrow PurgingBloodFailureFinancial HardshipGraft FailureCirculating BiomarkersEnrollmentChestEngraftmentDonor PersonEnzymes
Grant awards (7)
Non-invasive assessment of graft vs host disease using optoacoustic imaging$193,195
R21 · FY2024 · CA · contact PI
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT$581,140
R01 · FY2023 · HL
Non-invasive assessment of graft vs host disease using optoacoustic imaging$169,469
R21 · FY2023 · CA · contact PI
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT$569,118
R01 · FY2022 · HL
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT$565,274
R01 · FY2021 · HL
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT$553,550
R01 · FY2020 · HL
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT$644,631
R01 · FY2019 · HL